Source: The Patriot Light | AWK Network | VIEW ORIGINAL POST ==>
New research from Hudson Institute of Medical Research uncovers clues to treating ‘invisible’ cancer.
Groundbreaking research published in Nature Immunology offers new hope for patients with small cell lung cancer (SCLC), one of the most aggressive and deadly forms of lung cancer.
Australian scientists have discovered how to make “cold tumours” visible to the immune system, paving the way for treatments that would prevent the cancer from spreading and improve survival rates.
The study, a collaboration between Hudson Institute of Medical Research, Monash Health, Cancer Care Manitoba, and Peninsula Oncology, highlights the crucial role of the immune system in detecting tumours and preventing their migration.
“The innate immune system is often associated with the body’s response to infection. We show that it is also critical for the body to be able to ’see’ a tumour as it develops,” said Associate Professor Dan Gough from the Hudson Institute of Medical Research in Victoria.
“Without this immune visibility, tumours rapidly spread.”
Cracking the Code of ‘Cold Tumours’
Lead researcher Aleks Guanizo explained that the study identified a key process needed for the…
